|
Volumn 10, Issue 2 Suppl 1, 2007, Pages 23-30
|
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
a a a a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
BENZAZEPINE DERIVATIVE;
NICOTINIC RECEPTOR;
QUINOXALINE DERIVATIVE;
VARENICLINE;
BEHAVIOR THERAPY;
CLINICAL PRACTICE;
DIRECTIVE COUNSELING;
DRUG EFFECT;
HOSPITALIZATION;
HUMAN;
INTERNET;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
PHYSICIAN ATTITUDE;
REVIEW;
RISK REDUCTION;
SMOKING CESSATION;
TOBACCO DEPENDENCE;
BEHAVIOR THERAPY;
BENZAZEPINES;
BUPROPION;
COMBINED MODALITY THERAPY;
DIRECTIVE COUNSELING;
HOSPITALIZATION;
HUMANS;
INTERNET;
PHYSICIAN'S PRACTICE PATTERNS;
PHYSICIAN'S ROLE;
QUINOXALINES;
RECEPTORS, NICOTINIC;
RISK REDUCTION BEHAVIOR;
SMOKING CESSATION;
TOBACCO USE DISORDER;
MLCS;
MLOWN;
|
EID: 34447522110
PISSN: 1520037X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1520-037x.2007.05992.x Document Type: Review |
Times cited : (10)
|
References (63)
|